ctrl K

Watchlist Price Alert

Heart Test Laboratories I... (HSCS)

NASDAQ: HSCS · Real-Time Price · USD

3.97

0.10 (2.72%)

At close: May 23, 2025, 11:44 AM

Heart Test Laboratories Income Statement

Financials in USD. Fiscal year is May - April.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021	Apr 30, 2020
Revenue	18.6K	5.15K	14.37K	25.6K	64.18K
Cost of Revenue	6.08K	2.8K	7.89K	10.66K	46.46K
Gross Profit	12.52K	2.35K	6.48K	14.94K	17.72K
Operating Income	-6.31M	-6.11M	-4.71M	-2.57M	-3.82M
Interest Income	n/a	243.17K	371.62K	132.45K	2.81K
Pretax Income	-6.61M	-6.35M	-4.83M	-2.45M	-3.81M
Net Income	-6.61M	-490.85M	-4.58M	-2.58M	-3.83M
Selling & General & Admin	3.44M	3.65M	1.71M	874.62K	1.8M
Research & Development	2.88M	2.46M	3M	1.71M	2.04M
Other Expenses	n/a	1.85K	2.56K	-3.45K	19.89K
Operating Expenses	6.32M	6.12M	4.72M	2.58M	3.84M
Interest Expense	354.08K	243.17K	371.62K	132.45K	2.81K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	6.32M	6.12M	4.72M	2.59M	3.88M
Income Tax Expense	n/a	484.5M	-250.2K	129K	22.7K
Shares Outstanding (Basic)	352.52K	79.5K	33.19K	33.14K	33.14K
Shares Outstanding (Diluted)	352.52K	79.5K	33.19K	33.14K	33.14K
EPS (Basic)	-18.74	-6.17K	-137.94	-77.89	-115.69
EPS (Diluted)	-18.74	-6.17K	-137.94	-77.89	-115.69
EBITDA	-6.16M	-6.08M	-4.43M	-2.29M	-3.74M
EBIT	-6.25M	-6.11M	-4.46M	-2.32M	-3.81M
Depreciation & Amortization	95.13K	26.91K	26.57K	33.61K	63.83K